Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-014226
Filing Date
2024-12-23
Accepted
2024-12-23 17:36:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27695
2 filename2.txt TEXT-EXTRACT 1195
  Complete submission text file 0000000000-24-014226.txt   40148
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filed for) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-283993
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)